23.29
Celldex Therapeutics Inc Stock (CLDX) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
96.22%
0.156
|
4.131 | 1.517 | 0.268 | 0.967 |
|
20.78%
40.76
|
51.46 | 42.76 | 33.47 | 33.44 |
Benefits Costs and Expenses |
5.48%
40.76
|
38.65 | 42.76 | 33.47 | 33.44 |
Costs And Expenses |
21.24%
40.76
|
51.76 | 42.76 | 33.47 | 33.44 |
Operating Income/Loss |
14.74%
-40.61
|
-47.63 | -41.24 | -33.20 | -32.47 |
Income/Loss From Continuing Operations Before Tax |
17.66%
-40.61
|
-34.51 | -41.24 | -30.50 | -29.36 |
Income/Loss From Continuing Operations After Tax |
353.21%
-32.81
|
-7.239 | -38.26 | -30.50 | -29.36 |
|
24.24%
-32.81
|
-43.31 | -38.26 | -30.50 | -29.36 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4,782%
0.0589
|
0.00121 | 0.0473 | 0.0473 | 0.0472 |
Diluted Average Shares |
4,782%
0.0589
|
0.00121 | 0.0473 | 0.0473 | 0.0472 |
Basic Earnings Per Share |
33.33%
-0.56
|
-0.84 | -0.81 | -0.65 | -0.62 |
Diluted Earnings Per Share |
33.33%
-0.56
|
-0.84 | -0.81 | -0.65 | -0.62 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):